Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromes - Groupe Réponse immunitaire aux pathogènes et au soi altéré / Immune Response to Pathogens and altered-self Group (IBS-IRPAS) Access content directly
Journal Articles Oncotarget Year : 2017

Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromes

Patrice Faure
  • Function : Author
  • PersonId : 870588
Fichier principal
Vignette du fichier
oncotarget-v8i62-22299.pdf (6.76 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

hal-01929396 , version 1 (14-04-2024)

Identifiers

Cite

Mathieu Meunier, Sarah Ancelet, Christine Lefebvre, Josyane Arnaud, Catherine Garrel, et al.. Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromes. Oncotarget, 2017, 8 (62), ⟨10.18632/oncotarget.22299⟩. ⟨hal-01929396⟩
933 View
1 Download

Altmetric

Share

Gmail Facebook X LinkedIn More